Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GLOSTRUP FYSIOTERAPI & TRÆNING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   7.0% 8.1% 8.1% 10.2% 6.1% 6.1% 17.7% 17.4%   Credit score (0-100)   36 30 29 23 37 38 9 9   Credit rating   BBB BB BB BB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,886 4,671 5,793 5,578 6,046 5,621 0.0 0.0   EBITDA   444 91.0 -29.7 88.6 516 354 0.0 0.0   EBIT   264 -53.8 -161 -27.0 404 245 0.0 0.0   Pre-tax profit (PTP)   233.8 -61.9 -173.5 -52.6 383.0 239.6 0.0 0.0   Net earnings   183.9 -73.5 -158.0 -60.2 285.1 171.3 0.0 0.0   Pre-tax profit without non-rec. items   234 -61.9 -174 -52.6 383 240 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   820 675 613 695 583 1,310 0.0 0.0   Shareholders equity total   314 240 82.4 22.1 307 478 353 353   Interest-bearing liabilities   2,100 1,840 2,283 2,423 2,369 2,493 0.0 0.0   Balance sheet total (assets)   3,085 3,039 3,240 2,898 3,494 4,181 353 353   Net Debt   2,099 1,836 2,282 2,423 2,271 2,493 -353 -353     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,886 4,671 5,793 5,578 6,046 5,621 0.0 0.0   Gross profit growth   -8.2% -20.6% 24.0% -3.7% 8.4% -7.0% -100.0% 0.0%   Employees   11 9 16 10 10 9 0 0   Employee growth %   0.0% -18.2% 77.8% -37.5% 0.0% -10.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,085 3,039 3,240 2,898 3,494 4,181 353 353   Balance sheet change%   9.2% -1.5% 6.6% -10.6% 20.6% 19.6% -91.5% 0.0%   Added value   443.8 91.0 -29.7 88.6 520.0 354.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -290 -289 -194 -34 -224 618 -1,310 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 -3.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.5% -1.2% -2.8% -0.5% 6.7% 4.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.4% 0.4% -2.9% 1.3% 15.0% 8.8% 0.0% 0.0%   ROI %   13.7% 0.6% -4.0% 1.7% 18.7% 11.9% 0.0% 0.0%   ROE %   59.5% -26.5% -97.9% -115.3% 173.1% 43.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   10.2% 7.9% 2.5% 0.8% 8.8% 11.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   472.9% 2,018.3% -7,675.9% 2,735.5% 439.8% 704.0% 0.0% 0.0%   Gearing %   669.1% 765.5% 2,771.9% 10,954.0% 771.0% 521.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 3.8% 4.0% 3.9% 4.0% 4.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.8 0.8 0.8 0.7 0.9 0.7 0.0 0.0   Current Ratio   0.8 0.8 0.8 0.7 0.9 0.8 0.0 0.0   Cash and cash equivalent   1.0 3.5 0.8 0.4 97.6 0.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -569.6 -470.3 -605.6 -747.8 -350.7 -896.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   40 10 -2 9 52 39 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   40 10 -2 9 52 39 0 0   EBIT / employee   24 -6 -10 -3 40 27 0 0   Net earnings / employee   17 -8 -10 -6 29 19 0 0